More on REGN

- Summary
- Chart
- Profile
- Historical


- Earnings (+16.2% Growth)
- Ratings (6.1 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/5/22 *Est.)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

REGN Income Statement

Click line-items for a historical chart and %
Sanofi collaboration revenue
Other collaboration revenue 191.3M
Technology licensing
Net product sales 857.47M
Contract research and other
Total revenues 1.22B
Research and development 543.05M
Selling, general, and administrative 270.05M
Cost of goods sold 29.9M
Total expenses 857.32M
Loss from operations 362.8M
Other income (expense)
Investment income 3.3M
Interest expense
Total other income (expense) 3.08M
Net loss before income tax benefit 365.88M
Income tax benefit -101.08M
Net loss 264.8M
Net loss per share, basic and diluted
Weighted average shares outstanding, basic and diluted